| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.19 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |